Safety and Efficacy of Novel Combination Therapy with Bortezomib, Dexamethasone, Cyclophosphamide, and Lenalidomide in Newly Diagnosed Multiple Myeloma: Initial Results from the Phase I/II Multi-Center EVOLUTION Study
Year: 2008
Type: article
Source: Blood
Authors: Shaji Kumar, Ian W Flinn, Stephen J. Noga, Parameswaran Hari, Robert M. Rifkin, Natalie Scott Callander, Manish Bhandari, Jeffrey Lee Wolf, Cristina Gasparetto, Amrita Krishnan, Daren D Grosman, Jonathan Glass, Entezam Asim Sahovic, Hongliang Shi, Iain J. Webb, Paul Richardson, S. Vincent Rajkumar
Institutions: Mayo Clinic, Medical College of Wisconsin, Rocky Mountain Cancer Centers, University of Wisconsin–Madison, Christ Hospital, University of California, San Francisco, Duke University, Duke Medical Center, City Of Hope National Medical Center, Memorial Healthcare System, Feist-Weiller Cancer Center, Louisiana State University Health Sciences Center Shreveport, Western Pennsylvania Hospital, Takeda Oncology (United States), Dana-Farber Cancer Institute
Language: English
Subfield: Hematology
Field: Medicine
Domain: Health Sciences
Open Access status: closed
OpenAlex ID: W2572099565